ClinVar Miner

Submissions for variant NM_020975.6(RET):c.1902_1903inv (p.Cys634_Arg635delinsTrpGly)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001949601 SCV002237824 pathogenic Multiple endocrine neoplasia, type 2 2021-08-06 criteria provided, single submitter clinical testing This variant, c.1902_1903delinsGG, is a complex sequence change that results in the deletion of two and insertion of two amino acid(s) amino acid(s) in the RET protein (p.Cys634_Arg635delinsTrpGly). The frequency data for this variant in the population databases is not available, as this variant may be reported as separate entries in the ExAC database. This variant disrupts the p.Cys634 amino acid residue in RET. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7824936, 7907913, 12000816). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. A different variant (c.1902C>G) giving rise to one of the amino acid changes in this complex sequence change (p.Cys634Trp) has been determined to be pathogenic (PMID: 11939755, 24331334, 7824936). This suggests that this variant is also likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.